Belfast Telegraph

Thursday 18 September 2014

11. Almac Group

Chief executive: Alan Armstrong

Employment: 2,638

Turnover: £251m

Pre-tax profit: £14.4m

Craigavon-based Almac provides a range of integrated drug development services to the pharmaceutical and biotech industry.

Despite the ongoing economic slowdown, Almac’s global turnover has increased in the past year by 12% to £251m. During the same period their employment increased by 13.4% and now stands at 2,838.

Almac’s new $120m North American HQ is now fully operational.

The 240,000 sq ft facility houses its clinical services and and clinical technologies divisions as well as an extensive analytical suite. In Craigavon, work has commenced on a new £3m three-storey facility that will accommodate 225 staff.

January marked a year since the death of the company’s inspirational chairman Sir Allen McClay. He founded Almac in 2000, buying five divisions from his former venture Galen, in order to keep jobs in Northern Ireland.

Almac works with all the major pharmaceutical companies, hundreds of biotechs and now sends product to more than 100 countries worldwide.

Contact Us

Almac House,

Seagoe Industrial Estate,

Craigavon,

BT63 5QD

Tel: 028 3833 2200

www.almacgroup.com

COMMENT RULES: Comments that are judged to be defamatory, abusive or in bad taste are not acceptable and contributors who consistently fall below certain criteria will be permanently blacklisted. The moderator will not enter into debate with individual contributors and the moderator’s decision is final. It is Belfast Telegraph policy to close comments on court cases, tribunals and active legal investigations. We may also close comments on articles which are being targeted for abuse. Problems with commenting? customercare@belfasttelegraph.co.uk

Comment

More

Company Profiles

More

Help & Advice

More

People on the move

More